analyst
AD
NASDAQ · ADPT
Adaptive Biotechnologies Corporation
Healthcare · Biotechnology
$24.74
Up+$0.28 (+1.14%)
Updated Aug 16, 2026, 12:27 PM
SID Score
6.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 2.45B
- P/E ratio
- -41.23
- Dividend yield
- 0.00%
- 52-week range
- $11.92 – $26.16
- Volume
- 1.74M
- Avg. volume
- 2.26M
Price performance
ADPT price history
1M range · 20 trading sessions · Daily adjusted prices
ADPT closed at $24.74 after 20 trading sessions, up 13.17% for the selected period.
- Last close
- $24.74
- Period change
- +13.17%
- Period low
- $21.86
- Period high
- $25.45
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 14, 2026 | $24.27 | $24.95 | $24.00 | $24.74 | 1.74M |
| Aug 13, 2026 | $25.54 | $25.54 | $24.41 | $24.46 | 1.54M |
| Aug 12, 2026 | $25.34 | $25.54 | $24.865 | $25.25 | 1.71M |
| Aug 11, 2026 | $25.38 | $26.09 | $25.0085 | $25.39 | 2.96M |
| Aug 10, 2026 | $24.90 | $26.155 | $24.65 | $25.45 | 2.37M |
| Aug 7, 2026 | $24.69 | $24.95 | $24.28 | $24.93 | 2.5M |
| Aug 6, 2026 | $24.58 | $24.58 | $23.41 | $23.60 | 2.47M |
| Aug 5, 2026 | $24.54 | $24.96 | $24.22 | $24.60 | 2.42M |
| Aug 4, 2026 | $23.60 | $24.62 | $23.03 | $24.55 | 3.29M |
| Aug 3, 2026 | $22.915 | $23.56 | $21.829 | $23.11 | 2.59M |
| Jul 31, 2026 | $24.568 | $24.568 | $22.41 | $22.57 | 2.99M |
| Jul 30, 2026 | $22.20 | $24.34 | $22.065 | $24.18 | 5.28M |
| Jul 29, 2026 | $22.48 | $23.0799 | $21.74 | $22.56 | 3.15M |
| Jul 28, 2026 | $22.72 | $22.9899 | $21.93 | $22.52 | 1.68M |
| Jul 27, 2026 | $22.70 | $23.00 | $21.78 | $22.54 | 2.44M |
| Jul 24, 2026 | $22.56 | $22.77 | $21.83 | $22.27 | 2.82M |
| Jul 23, 2026 | $21.95 | $22.91 | $21.95 | $22.31 | 2.76M |
| Jul 22, 2026 | $22.25 | $22.65 | $21.54 | $21.95 | 2.36M |
| Jul 21, 2026 | $21.63 | $22.60 | $20.90 | $22.58 | 3.51M |
| Jul 20, 2026 | $22.54 | $22.90 | $21.63 | $21.86 | 2.14M |
Latest ADPT news
The latest Smart Investors Daily articles mentioning ADPT.
Stock researchResearch & News · SEC Filings
Loading stock research…

